May 2 , 2023
                                                                          917 days 
                                      960
                                    
                                   
								   
                                
                                
                                    
	- GlaxoSmithKline Pharmaceuticals Ltd. (GSK) announced the launch of its shingles vaccine in India.
 
	- The vaccine, named Shingrix, is one of the best-selling products of the company.
 
	- Shingles is a viral infection that causes a painful rash and it can occur anywhere in the body.
 
	- This is caused by the varicella-zoster virus.
 
	- Shingrix is the world’s first non-live, recombinant subunit vaccine that is given intramuscularly in two doses.
 

                                 
                            
                                
                                Post Views: 
                                960